Advertisement

C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease

  • Erik M. Stuveling
    Affiliations
    Department of Internal Medicine, University Medical Centre Groningen, Groningen, The Netherlands
    Search for articles by this author
  • Hans L. Hillege
    Affiliations
    Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands
    Search for articles by this author
  • Stephan J.L. Bakker
    Affiliations
    Department of Internal Medicine, University Medical Centre Groningen, Groningen, The Netherlands
    Search for articles by this author
  • Folkert W. Asselbergs
    Affiliations
    Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands
    Search for articles by this author
  • Paul E. de Jong
    Affiliations
    Division of Nephrology, University Medical Centre Groningen, Groningen, The Netherlands
    Search for articles by this author
  • Reinold O.B. Gans
    Affiliations
    Department of Internal Medicine, University Medical Centre Groningen, Groningen, The Netherlands
    Search for articles by this author
  • Dick de Zeeuw
    Correspondence
    Corresponding author. Tel.: +31-50-363-2810; fax: +31-50-363-2812.
    Footnotes
    Affiliations
    Department of Clinical Pharmacology, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
    Search for articles by this author
  • PREVEND study group
    e1
  • Author Footnotes
    1 The PREVEND study group consists of: P.E. de Jong, G.J. Navis, R.T. Gansevoort, J.C. Verhave, Division of Nephrology, Department of Medicine, University Medical Centre Groningen. D. de Zeeuw, W.H. van Gilst, R.H. Henning, Department of Clinical Pharmacology, University Medical Centre Groningen. R.O.B. Gans, S.J.L. Bakker, A.J. Smit, A.M. van Roon, E.M. Stuveling, Division of Vascular Medicine, Department of Medicine, University Medical Centre Groningen. D.J. van Veldhuisen, H.L. Hillege, A.J. van Boven, F.W. Asselbergs, C.P. Baljé-Volkers, Department of Cardiology, University Medical Centre Groningen. R.P.F. Dullaart, Division of Endocrinology, Department of Medicine, University Medical Centre Groningen. G.J. tc Meerman, G.-T. Spijker, Department of Medical Genetics, University Medical Centre Groningen. V. Fidler, J.G.M. Burgerhof, Department of Epidemiology and Statistics. LT.W. de Jong-van den Berg, M.J. Postma, J. van den Berg, Department of Phamaco-Epidemiology. J.H.J. Muntinga, Department of Medical Physiology. D.E. Grobbee, Department of Epidemiology, Julius Center, Utrecht.
    e1 [email protected]

      Abstract

      C-reactive protein (CRP) and microalbuminuria (MA) have been identified as risk markers for cardiovascular disease (CVD). We questioned whether CRP and MA are similar markers of vascular disease in different regions of the vascular tree like the heart, kidneys and extremities or if they differ in their relationships with these vascular beds. Baseline levels of CRP and urinary albumin were measured in 6669 non-diabetic participants in the Prevention of Renal and Vascular ENdstage Disease (PREVEND) study, a Dutch cohort derived from the general population. We defined three domains of vascular disease; coronary heart disease (myocardial infarction or infarct pattern on the ECG), renal insufficiency (creatinine clearance <60 ml min−1) and peripheral artery disease (ankle brachial index <0.9 or lower limb revascularisation). The prevalence of an elevated CRP (27.7 vs. 17.9%) and MA (17.5 vs. 10.4%) were increased in subjects with vascular disease as compared with subjects without CVD. The prevalence of an elevated CRP was equal in subjects with either coronary heart disease, renal insufficiency or peripheral artery disease (28.4 vs. 29.5 vs. 26.0%, NS), whereas MA was most prevalent in subjects with coronary heart disease (22.5 vs. 12.8 vs. 14.9%, P<0.05). Using multivariate analyses, CRP was independently associated with all three domains of vascular disease, whereas MA was independently associated with coronary heart disease only. In addition, we found synergistic contributions of an elevated CRP and older age to the risk of vascular disease in all three domains. Thus, CRP and MA are risk markers for vascular disease, each showing a different risk profiling for different vascular beds.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jager A.
        • van Hinsbergh V.W.
        • Kostense P.J.
        • et al.
        C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.
        Arterioscler. Thromb. Vasc. Biol. 2002; 22: 593-598
        • Mendall M.A.
        • Patel P.
        • Ballam L.
        • Strachan D.
        • Northfield T.C.
        C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study.
        Br. Med. J. 1996; 312: 1061-1065
        • Ridker P.M.
        • Buring J.E.
        • Shih J.
        • Matias M.
        • Hennekens C.H.
        Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women (see comments).
        Circulation. 1998; 98: 731-733
        • Gussekloo J.
        • Schaap M.C.
        • Frolich M.
        • Blauw G.J.
        • Westendorp R.G.
        C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons.
        Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1047-1051
        • Stuveling E.M.
        • Hillege H.L.
        • Bakker S.J.
        • Gans R.O.
        • de Jong P.E.
        • De Zeeuw D.
        C-reactive protein is associated with renal function abnormalities in a non-diabetic population.
        Kidney Int. 2003; 63: 654-661
        • Ridker P.M.
        • Cushman M.
        • Stampfer M.J.
        • Tracy R.P.
        • Hennekens C.H.
        Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.
        Circulation. 1998; 97: 425-428
        • Erren M.
        • Reinecke H.
        • Junker R.
        • et al.
        Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries.
        Arterioscler. Thromb. Vasc. Biol. 1999; 19: 2355-2363
        • Strandberg T.E.
        • Tilvis R.S.
        C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly.
        Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1057-1060
        • Clausen P.
        • Jensen J.S.
        • Jensen G.
        • Borch-Johnsen K.
        • Feldt-Rasmussen B.
        Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects.
        Circulation. 2001; 103: 1869-1874
        • Mykkanen L.
        • Zaccaro D.J.
        • O'Leary D.H.
        • Howard G.
        • Robbins D.C.
        • Haffner S.M.
        Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS).
        Stroke. 1997; 28: 1710-1716
        • Standl E.
        • Stiegler H.
        Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area.
        Diabetologia. 1993; 36: 1017-1020
        • Yudkin J.S.
        • Forrest R.D.
        • Jackson C.A.
        Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey.
        Lancet. 1988; 2: 530-533
        • Nelson R.G.
        • Bennett P.H.
        • Beck G.J.
        • et al.
        Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.
        New Engl. J. Med. 1996; 335: 1636-1642
        • Festa A.
        • D'Agostino R.
        • Howard G.
        • Mykkanen L.
        • Tracy R.P.
        • Haffner S.M.
        Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the insulin resistance atherosclerosis study.
        Kidney Int. 2000; 58: 1703-1710
        • Pannacciulli N.
        • Cantatore F.P.
        • Minenna A.
        • Bellacicco M.
        • Giorgino R.
        • De Pergola G.
        Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women.
        J. Int. Med. 2001; 250: 502-507
        • Pinto-Sietsma S.J.
        • Janssen W.M.
        • Hillege H.L.
        • Navis G.
        • De Zeeuw D.
        • de Jong P.E.
        Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population.
        J. Am. Soc. Nephrol. 2000; 11: 1882-1888
        • Culleton B.F.
        • Larson M.G.
        • Wilson P.W.
        • Evans J.C.
        • Parfrey P.S.
        • Levy D.
        Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency.
        Kidney Int. 1999; 56: 2214-2219
        • Manjunath G.
        • Tighiouart H.
        • Coresh J.
        • et al.
        Level of kidney function as a risk factor for cardiovascular outcomes in the elderly.
        Kidney Int. 2003; 63: 1121-1129
        • Weitz J.I.
        • Byrne J.
        • Clagett G.P.
        • et al.
        Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review.
        Circulation. 1996; 94: 3026-3049
      1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diab. Care 1997;20:1183–97.

        • Hak A.E.
        • Stehouwer C.D.
        • Bots M.L.
        • et al.
        Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women.
        Arterioscler. Thromb. Vasc. Biol. 1999; 19: 1986-1991
        • Valensi P.
        • Assayag M.
        • Busby M.
        • Paries J.
        • Lormeau B.
        • Attali J.R.
        Microalbuminuria in obese patients with or without hypertension.
        Int. J. Obes. Relat. Metab. Disord. 1996; 20: 574-579
        • Chae C.U.
        • Lee R.T.
        • Rifai N.
        • Ridker P.M.
        Blood pressure and inflammation in apparently healthy men.
        Hypertension. 2001; 38: 399-403
        • Pinto-Sietsma S.J.
        • Mulder J.
        • Janssen W.M.
        • Hillege H.L.
        • De Zeeuw D.
        • de Jong P.E.
        Smoking is related to albuminuria and abnormal renal function in nondiabetic persons.
        Ann. Int. Med. 2000; 133: 585-591
        • Bermudez E.A.
        • Rifai N.
        • Buring J.E.
        • Manson J.E.
        • Ridker P.M.
        Relation between markers of systemic vascular inflammation and smoking in women.
        Am. J. Cardiol. 2002; 89: 1117-1119
        • Yudkin J.S.
        • Stehouwer C.D.
        • Emeis J.J.
        • Coppack S.W.
        C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue.
        Arterioscler. Thromb. Vasc. Biol. 1999; 19: 972-978
        • Campese V.M.
        • Bianchi S.
        • Bigazzi R.
        Association between hyperlipidemia and microalbuminuria in essential hypertension.
        Kidney Int. Suppl. 1999; 71: S10-S13
        • Stehouwer C.D.
        • Gall M.A.
        • Twisk J.W.
        • Knudsen E.
        • Emeis J.J.
        • Parving H.H.
        Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.
        Diabetes. 2002; 51: 1157-1165
        • Deckert T.
        • Feldt-Rasmussen B.
        • Borch-Johnsen K.
        • Jensen T.
        • Kofoed-Enevoldsen A.
        Albuminuria reflects widespread vascular damage. The steno hypothesis.
        Diabetologia. 1989; 32: 219-226
        • Mogensen C.E.
        Early glomerular hyperfiltration in insulin-dependent diabeties and late nephropathy.
        Scand. J. Clin. Lab. Invest. 1986; 46: 201-206
        • Garg A.X.
        • Clark W.F.
        • Haynes R.B.
        • House A.A.
        Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I.
        Kidney Int. 2002; 61: 1486-1494
        • Muntner P.
        • He J.
        • Hamm L.
        • Loria C.
        • Whelton P.K.
        Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.
        J. Am. Soc. Nephrol. 2002; 13: 745-753
        • Diamond J.R.
        Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis.
        Kidney Int. Suppl. 1991; 31: S29-S34
        • Ruilope L.M.
        The kidney as part of the cardiovascular system.
        J. Cardiovasc. Pharmacol. 1999; 33: S7-S10
        • Kluft C.
        • de Maat M.P.
        Determination of the habitual low blood level of C-reactive protein in individuals.
        Ital. Heart J. 2001; 2: 172-180